Department of Surgery (Hepatobiliary and Pancreatic Surgery)
Director：EBATA, Tomoki (Professor)
Experienced staff do their utmost to treat digestive diseases, mainly tumors
We mainly provide a surgical treatment for hepato-biliary-pancreatic tumors and retroperitoneal tumors.
Medical Care System
Two attendings are leading our teams consist of 30 well experienced surgeons, who have 8 years training in our associated hospital network, and providing a best practice in the inpatient clinic. The outpatient clinic by experts in hepatobiliary and pancreatic surgery is open every day.
Target Diseases
Malignant tumors such as liver cancers (primary/ metastatic), biliary tract cancers, pancreatic cancers, benign diseases such as gallstone, and retroperitoneal tumors
Strong Fields
Nagoya University Department of Surgery has been recognized for outstanding performance of extended surgery with highly invasiveness and demanding technical difficulty on perihilar cholangiocarcinoma, pancreatic cancer, and retroperitoneal tumors. We also perform minimal invasive surgery including laparoscopic/robotic approaches.
Clinical Results
In 2023, hepatectomy for biliary cancer: 52; other hepatectomies: 78 (laparoscopic: 26; robotic: 15); pancreatoduodenectomy: 98 (laparoscopic: 4; robotic: 1); distal pancreatectomy: 36 (laparoscopic: 14; robotic: 11); surgery for retroperitoneal tumor: 75
Advanced Medicine and Research
We conduct multi-center clinical trials for chemotherapy targeting hepatobiliary and pancreatic cancers, as well as research for the development of nucleic acid drugs and diagnostic models using AI.
-
- 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560
- 052-741-2111